FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000UL812V6

Market Closed - Deutsche Boerse AG 11:06:29 07/06/2024 pm IST
4.38 EUR -4.58% Intraday chart for FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month-0.68%
1 month-3.31%
Date Price Change
07/24/07 4.38 -4.58%
06/24/06 4.59 +1.55%
05/24/05 4.52 +0.44%
04/24/04 4.5 +2.51%
03/24/03 4.39 -0.45%

Delayed Quote Deutsche Boerse AG

Last update June 07, 2024 at 11:06 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer UBS
WKN UL812V
ISINDE000UL812V6
Date issued 23/10/2023
Strike 175.7 $
Maturity Unlimited
Parity 5.8 : 1
Emission price 5.02
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.14
Lowest since issue 2.96
Spread 0.15
Spread %3.24%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
147.1 USD
Average target price
171.7 USD
Spread / Average Target
+16.75%
Consensus